National Health Insurance Service Ilsan Hospital Researcher Has Provided New Study Findings on Type 2 Diabetes (Age at Mortality in Patients with Type 2 Diabetes Who Underwent Kidney Transplantation: An Analysis of Data from the Korean National …): Nutritional and Metabolic Diseases and Conditions – Type 2 Diabetes

2023 MAY 11 (NewsRx) -- By a News Reporter-Staff News Editor at Information Technology Business Daily -- Data detailed on type 2 diabetes have been presented. According to news reporting originating from Goyang, South Korea, by NewsRx correspondents, research stated, “Although the clinical outcomes of diabetes have improved, diabetes remains the principal cause of end-stage renal disease. The aim of the study is to investigate whether mortality trends in individuals with type 2 diabetes and kidney transplantation (KT) have changed.”

Funders for this research include National Health Insurance Ilsan Hospital Grant.

The news journalists obtained a quote from the research from National Health Insurance Service Ilsan Hospital: “This study analyzed data from the National Health Insurance Service claims database linked to death records from the National Statistical Information Service in Korea. Information from a total of 2521 deaths of KT recipients was collected from 2006 to 2018. The age at death of KT recipients increased from 57.4 years in 2006 to 65.2 years in 2018, with a mean change of +0.65 years/year (p < 0.001). The overall age at death increased by 0.55 and 0.66 years/year in the type 2 diabetes and non-diabetes populations, respectively. The age at death was significantly higher in the type 2 diabetes group, and was maintained during the study period. The proportion of death due to malignancy and cerebrovascular and heart disease was maintained, that due to type 2 diabetes decreased and that due to pneumonia increased. Neither diabetes nor hypertension determined the age at death, and the age at KT was the most prominent factor affecting age at death in KT recipients.”

According to the news reporters, the research concluded: “The age at death in KT recipients increased over the 12 years between 2006 and 2018, with similar trends in the type 2 diabetes and non-diabetes groups. The age at KT was higher in patients with type 2 diabetes, and was the main contributor to the age at death in KT recipients.”

For more information on this research see: Age at Mortality in Patients with Type 2 Diabetes Who Underwent Kidney Transplantation: An Analysis of Data from the Korean National Health Insurance and Statistical Information Service, 2006 to 2018. Journal of Clinical Medicine, 2023,12(9). (Journal of Clinical Medicine - http://www.mdpi.com/journal/jcm). The publisher for Journal of Clinical Medicine is MDPI AG.

A free version of this journal article is available at https://doi.org/10.3390/jcm12093160.

Our news editors report that additional information may be obtained by contacting Sun Ok Song, Divison of Endocrinology, Department of Internal Medicine, National Health Insurance Service Ilsan Hospital, Goyang 10444, South Korea. Additional authors for this research include Eugene Han, Kang Ju Son, Bong-Soo Cha, Byung-Wan Lee.

ORCID is an identifier for authors and includes bibliographic information. The following is ORCID information for the authors of this research: Sun Ok Song (http://orcid.org/0000-0003-4829-3407), Eugene Han (http://orcid.org/0000-0002-3237-3317), Byung-Wan Lee (http://orcid.org/0000-0002-9899-4992).

(Our reports deliver fact-based news of research and discoveries from around the world.)